Cargando…

Procoagulant, Tissue Factor-Bearing Microparticles in Bronchoalveolar Lavage of Interstitial Lung Disease Patients: An Observational Study

Coagulation factor Xa appears involved in the pathogenesis of pulmonary fibrosis. Through its interaction with protease activated receptor-1, this protease signals myofibroblast differentiation in lung fibroblasts. Although fibrogenic stimuli induce factor X synthesis by alveolar cells, the mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Novelli, Federica, Neri, Tommaso, Tavanti, Laura, Armani, Chiara, Noce, Concettina, Falaschi, Fabio, Bartoli, Maria Laura, Martino, Federica, Palla, Antonio, Celi, Alessandro, Paggiaro, Pierluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002423/
https://www.ncbi.nlm.nih.gov/pubmed/24777000
http://dx.doi.org/10.1371/journal.pone.0095013
_version_ 1782313799700709376
author Novelli, Federica
Neri, Tommaso
Tavanti, Laura
Armani, Chiara
Noce, Concettina
Falaschi, Fabio
Bartoli, Maria Laura
Martino, Federica
Palla, Antonio
Celi, Alessandro
Paggiaro, Pierluigi
author_facet Novelli, Federica
Neri, Tommaso
Tavanti, Laura
Armani, Chiara
Noce, Concettina
Falaschi, Fabio
Bartoli, Maria Laura
Martino, Federica
Palla, Antonio
Celi, Alessandro
Paggiaro, Pierluigi
author_sort Novelli, Federica
collection PubMed
description Coagulation factor Xa appears involved in the pathogenesis of pulmonary fibrosis. Through its interaction with protease activated receptor-1, this protease signals myofibroblast differentiation in lung fibroblasts. Although fibrogenic stimuli induce factor X synthesis by alveolar cells, the mechanisms of local posttranslational factor X activation are not fully understood. Cell-derived microparticles are submicron vesicles involved in different physiological processes, including blood coagulation; they potentially activate factor X due to the exposure on their outer membrane of both phosphatidylserine and tissue factor. We postulated a role for procoagulant microparticles in the pathogenesis of interstitial lung diseases. Nineteen patients with interstitial lung diseases and 11 controls were studied. All subjects underwent bronchoalveolar lavage; interstitial lung disease patients also underwent pulmonary function tests and high resolution CT scan. Microparticles were enumerated in the bronchoalveolar lavage fluid with a solid-phase assay based on thrombin generation. Microparticles were also tested for tissue factor activity. In vitro shedding of microparticles upon incubation with H(2)O(2) was assessed in the human alveolar cell line, A549 and in normal bronchial epithelial cells. Tissue factor synthesis was quantitated by real-time PCR. Total microparticle number and microparticle-associated tissue factor activity were increased in interstitial lung disease patients compared to controls (84±8 vs. 39±3 nM phosphatidylserine; 293±37 vs. 105±21 arbitrary units of tissue factor activity; mean±SEM; p<.05 for both comparisons). Microparticle-bound tissue factor activity was inversely correlated with lung function as assessed by both diffusion capacity and forced vital capacity (r(2) = .27 and .31, respectively; p<.05 for both correlations). Exposure of lung epithelial cells to H(2)O(2) caused an increase in microparticle-bound tissue factor without affecting tissue factor mRNA. Procoagulant microparticles are increased in interstitial lung diseases and correlate with functional impairment. These structures might contribute to the activation of factor X and to the factor Xa-mediated fibrotic response in lung injury.
format Online
Article
Text
id pubmed-4002423
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40024232014-05-02 Procoagulant, Tissue Factor-Bearing Microparticles in Bronchoalveolar Lavage of Interstitial Lung Disease Patients: An Observational Study Novelli, Federica Neri, Tommaso Tavanti, Laura Armani, Chiara Noce, Concettina Falaschi, Fabio Bartoli, Maria Laura Martino, Federica Palla, Antonio Celi, Alessandro Paggiaro, Pierluigi PLoS One Research Article Coagulation factor Xa appears involved in the pathogenesis of pulmonary fibrosis. Through its interaction with protease activated receptor-1, this protease signals myofibroblast differentiation in lung fibroblasts. Although fibrogenic stimuli induce factor X synthesis by alveolar cells, the mechanisms of local posttranslational factor X activation are not fully understood. Cell-derived microparticles are submicron vesicles involved in different physiological processes, including blood coagulation; they potentially activate factor X due to the exposure on their outer membrane of both phosphatidylserine and tissue factor. We postulated a role for procoagulant microparticles in the pathogenesis of interstitial lung diseases. Nineteen patients with interstitial lung diseases and 11 controls were studied. All subjects underwent bronchoalveolar lavage; interstitial lung disease patients also underwent pulmonary function tests and high resolution CT scan. Microparticles were enumerated in the bronchoalveolar lavage fluid with a solid-phase assay based on thrombin generation. Microparticles were also tested for tissue factor activity. In vitro shedding of microparticles upon incubation with H(2)O(2) was assessed in the human alveolar cell line, A549 and in normal bronchial epithelial cells. Tissue factor synthesis was quantitated by real-time PCR. Total microparticle number and microparticle-associated tissue factor activity were increased in interstitial lung disease patients compared to controls (84±8 vs. 39±3 nM phosphatidylserine; 293±37 vs. 105±21 arbitrary units of tissue factor activity; mean±SEM; p<.05 for both comparisons). Microparticle-bound tissue factor activity was inversely correlated with lung function as assessed by both diffusion capacity and forced vital capacity (r(2) = .27 and .31, respectively; p<.05 for both correlations). Exposure of lung epithelial cells to H(2)O(2) caused an increase in microparticle-bound tissue factor without affecting tissue factor mRNA. Procoagulant microparticles are increased in interstitial lung diseases and correlate with functional impairment. These structures might contribute to the activation of factor X and to the factor Xa-mediated fibrotic response in lung injury. Public Library of Science 2014-04-28 /pmc/articles/PMC4002423/ /pubmed/24777000 http://dx.doi.org/10.1371/journal.pone.0095013 Text en © 2014 Novelli et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Novelli, Federica
Neri, Tommaso
Tavanti, Laura
Armani, Chiara
Noce, Concettina
Falaschi, Fabio
Bartoli, Maria Laura
Martino, Federica
Palla, Antonio
Celi, Alessandro
Paggiaro, Pierluigi
Procoagulant, Tissue Factor-Bearing Microparticles in Bronchoalveolar Lavage of Interstitial Lung Disease Patients: An Observational Study
title Procoagulant, Tissue Factor-Bearing Microparticles in Bronchoalveolar Lavage of Interstitial Lung Disease Patients: An Observational Study
title_full Procoagulant, Tissue Factor-Bearing Microparticles in Bronchoalveolar Lavage of Interstitial Lung Disease Patients: An Observational Study
title_fullStr Procoagulant, Tissue Factor-Bearing Microparticles in Bronchoalveolar Lavage of Interstitial Lung Disease Patients: An Observational Study
title_full_unstemmed Procoagulant, Tissue Factor-Bearing Microparticles in Bronchoalveolar Lavage of Interstitial Lung Disease Patients: An Observational Study
title_short Procoagulant, Tissue Factor-Bearing Microparticles in Bronchoalveolar Lavage of Interstitial Lung Disease Patients: An Observational Study
title_sort procoagulant, tissue factor-bearing microparticles in bronchoalveolar lavage of interstitial lung disease patients: an observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002423/
https://www.ncbi.nlm.nih.gov/pubmed/24777000
http://dx.doi.org/10.1371/journal.pone.0095013
work_keys_str_mv AT novellifederica procoagulanttissuefactorbearingmicroparticlesinbronchoalveolarlavageofinterstitiallungdiseasepatientsanobservationalstudy
AT neritommaso procoagulanttissuefactorbearingmicroparticlesinbronchoalveolarlavageofinterstitiallungdiseasepatientsanobservationalstudy
AT tavantilaura procoagulanttissuefactorbearingmicroparticlesinbronchoalveolarlavageofinterstitiallungdiseasepatientsanobservationalstudy
AT armanichiara procoagulanttissuefactorbearingmicroparticlesinbronchoalveolarlavageofinterstitiallungdiseasepatientsanobservationalstudy
AT noceconcettina procoagulanttissuefactorbearingmicroparticlesinbronchoalveolarlavageofinterstitiallungdiseasepatientsanobservationalstudy
AT falaschifabio procoagulanttissuefactorbearingmicroparticlesinbronchoalveolarlavageofinterstitiallungdiseasepatientsanobservationalstudy
AT bartolimarialaura procoagulanttissuefactorbearingmicroparticlesinbronchoalveolarlavageofinterstitiallungdiseasepatientsanobservationalstudy
AT martinofederica procoagulanttissuefactorbearingmicroparticlesinbronchoalveolarlavageofinterstitiallungdiseasepatientsanobservationalstudy
AT pallaantonio procoagulanttissuefactorbearingmicroparticlesinbronchoalveolarlavageofinterstitiallungdiseasepatientsanobservationalstudy
AT celialessandro procoagulanttissuefactorbearingmicroparticlesinbronchoalveolarlavageofinterstitiallungdiseasepatientsanobservationalstudy
AT paggiaropierluigi procoagulanttissuefactorbearingmicroparticlesinbronchoalveolarlavageofinterstitiallungdiseasepatientsanobservationalstudy